Enhanced removal of nickel(II) ions from aqueous solutions by SDS-functionalized graphene oxide

por Salihi, Elif Çalışkan, Wang, Jiabin, Coleman, Daniel J. L., Šiller, Lidija
Publicado 2016

Determination of key structure–activity relationships in siRNA delivery with a mixed micelle system()()

por Omedes Pujol, Marta, Coleman, Daniel J.L., Allen, Christopher D., Heidenreich, Olaf, Fulton, David A.
Publicado 2013

Molecular Testing Identifies Determinants of Exceptional Response and Guides Precision Therapy in a Patient with Lethal, Treatment-emergent Neuroendocrine Prostate Cancer

por Turina, Claire B, Coleman, Daniel J, Thomas, George V, Fung, Alice W, Alumkal, Joshi J
Publicado 2019

Retinoid-X-Receptors (α/β) in Melanocytes Modulate Innate Immune Responses and Differentially Regulate Cell Survival following UV Irradiation

por Coleman, Daniel J., Garcia, Gloria, Hyter, Stephen, Jang, Hyo Sang, Chagani, Sharmeen, Liang, Xiaobo, Larue, Lionel, Ganguli-Indra, Gitali, Indra, Arup K.
Publicado 2014

Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature

por Volpe, Giacomo, Walton, David S., Grainger, David E., Ward, Carl, Cauchy, Pierre, Blakemore, Daniel, Coleman, Daniel J. L., Cockerill, Peter N., Garcia, Paloma, Frampton, Jon
Publicado 2017

GoPeaks: histone modification peak calling for CUT&Tag

por Yashar, William M., Kong, Garth, VanCampen, Jake, Curtiss, Brittany M., Coleman, Daniel J., Carbone, Lucia, Yardimci, Galip Gürkan, Maxson, Julia E., Braun, Theodore P.
Publicado 2022

Stable Epigenetic Programming of Effector and Central Memory CD4 T Cells Occurs Within 7 Days of Antigen Exposure In Vivo

por Bevington, Sarah L., Fiancette, Remi, Gajdasik, Dominika W., Keane, Peter, Soley, Jake K., Willis, Claire M., Coleman, Daniel J. L., Withers, David R., Cockerill, Peter N.
Publicado 2021

Integrative molecular network analysis identifies emergent enzalutamide resistance mechanisms in prostate cancer

por King, Carly J., Woodward, Josha, Schwartzman, Jacob, Coleman, Daniel J., Lisac, Robert, Wang, Nicholas J., Van Hook, Kathryn, Gao, Lina, Urrutia, Joshua, Dane, Mark A., Heiser, Laura M., Alumkal, Joshi J.
Publicado 2017

Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer

por Coleman, Daniel J., Gao, Lina, Schwartzman, Jacob, Korkola, James E., Sampson, David, Derrick, Daniel S., Urrutia, Joshua, Balter, Ariel, Burchard, Julja, King, Carly J., Chiotti, Kami E., Heiser, Laura M., Alumkal, Joshi J.
Publicado 2019

Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth

por Coleman, Daniel J.L., Keane, Peter, Luque-Martin, Rosario, Chin, Paulynn S, Blair, Helen, Ames, Luke, Kellaway, Sophie G., Griffin, James, Holmes, Elizabeth, Potluri, Sandeep, Assi, Salam A., Bushweller, John, Heidenreich, Olaf, Cockerill, Peter N., Bonifer, Constanze
Publicado 2023

Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4

por Coleman, Daniel J., Sampson, David A., Sehrawat, Archana, Kumaraswamy, Anbarasu, Sun, Duanchen, Wang, Yuzhuo, Schwartzman, Jacob, Urrutia, Joshua, Lee, Ahn R., Coleman, Ilsa M., Nelson, Peter S., Dong, Xuesen, Morrissey, Colm, Corey, Eva, Xia, Zheng, Yates, Joel A., Alumkal, Joshi J.
Publicado 2020

Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor

por Coleman, Daniel J., Van Hook, Kathryn, King, Carly J., Schwartzman, Jacob, Lisac, Robert, Urrutia, Joshua, Sehrawat, Archana, Woodward, Josha, Wang, Nicholas J., Gulati, Roman, Thomas, George V., Beer, Tomasz M., Gleave, Martin, Korkola, James E., Gao, Lina, Heiser, Laura M., Alumkal, Joshi J.
Publicado 2016

Subtype-specific regulatory network rewiring in acute myeloid leukemia

por Assi, Salam A., Imperato, Maria Rosaria, Coleman, Daniel J. L., Pickin, Anna, Potluri, Sandeep, Ptasinska, Anetta, Chin, Paulynn Suyin, Blair, Helen, Cauchy, Pierre, James, Sally R., Zacarias-Cabeza, Joaquin, Gilding, L. Niall, Beggs, Andrew, Clokie, Sam, Loke, Justin C., Jenkin, Phil, Uddin, Ash, Delwel, Ruud, Richards, Stephen J., Raghavan, Manoj, Griffiths, Michael J., Heidenreich, Olaf, Cockerill, Peter N., Bonifer, Constanze
Publicado 2018

BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program

por Kim, Dae-Hwan, Sun, Duanchen, Storck, William K., Welker Leng, Katherine, Jenkins, Chelsea, Coleman, Daniel J., Sampson, David, Guan, Xiangnan, Kumaraswamy, Anbarasu, Rodansky, Eva S., Urrutia, Joshua A., Schwartzman, Jacob A., Zhang, Chao, Beltran, Himisha, Labrecque, Mark P., Morrissey, Colm, Lucas, Jared M., Coleman, Ilsa M., Nelson, Peter S., Corey, Eva, Handelman, Samuel K., Sexton, Jonathan Z., Aggarwal, Rahul, Abida, Wassim, Feng, Felix Y., Small, Eric J., Spratt, Daniel E., Bankhead, Armand, Rao, Arvind, Gesner, Emily M., Attwell, Sarah, Lakhotia, Sanjay, Campeau, Eric, Yates, Joel A., Xia, Zheng, Alumkal, Joshi J.
Publicado 2021